Publications

HIV-1 variants in population-based national surveys in sub-Saharan Africa, 2015-2022.

Ghys PD. et al, (2026), AIDS (London, England)

Neonatal mortality attributable to preterm births associated with maternal HIV infection in sub-Saharan Africa, 1990-2020.

Nchinda N. and Hemelaar J., (2026), AIDS (London, England)

Antenatal prediction of small for gestational age at birth based on four birthweight standards using machine learning algorithms

Yu Q-Y. et al, (2026), Frontiers in Artificial Intelligence, 8

Comparative growth of children who are HIV-exposed and uninfected with those who are HIV-unexposed and uninfected at age 1 and 2 years in South Africa: a prospective cohort study

Carlqvist A. et al, (2025), eClinicalMedicine, 89, 103515 - 103515

BHIVA guidelines on the management of HIV in pregnancy and the postpartum period 2025

Byrne L. et al, (2025), HIV Medicine, 26, 1757 - 1880

Foetal growth in pregnant women with HIV.

Darji D. et al, (2025), AIDS (London, England), 39, 1568 - 1579

Association of nucleoside reverse transcriptase inhibitors with adverse perinatal outcomes in pregnant women living with HIV: systematic review and meta-analysis.

Cowdell I. et al, (2025), Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 31, 958 - 970

Paying more attention to HIV-1 recombinants among men who have sex with men–Author’s reply

Hemelaar J. et al, (2025), The Lancet Microbe, 6, 101059 - 101059

Evaluation of a two-tier preterm birth prevention service in a tertiary hospital in the United Kingdom: a retrospective cohort study.

Shea M. et al, (2025), BMC pregnancy and childbirth, 25

Perinatal outcomes among pregnant women with HIV initiating antiretroviral therapy preconception and antenatally.

Boering P. et al, (2025), AIDS (London, England), 39, 584 - 596

Adverse perinatal outcomes associated with different classes of antiretroviral drugs in pregnant women with HIV

Hey M. et al, (2025), AIDS, 39, 162 - 174

Prevalence and transmission of HIV-1 drug resistance mutations among patients with treatment failure and newly diagnosed people in Liangshan Prefecture, China, in 2021-2023.

Pei R. et al, (2025), Frontiers in public health, 13

The changing molecular epidemiology of HIV-1 in Liangshan prefecture, China, in 2021-2023.

Pei R. et al, (2025), Frontiers in microbiology, 16

Association of nucleoside reverse transcriptase inhibitors with adverse perinatal outcomes in pregnant women living with HIV: Systematic review and meta-analysis

Cowdell I. et al, (2025), BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 132, 109 - 109

Foetal growth in pregnant women with HIV

Darji D. et al, (2025), AIDS, 39, 1568 - 1579

Cookies on this website

Search results (72)